-
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma
Korst, C. L. B. M., O'Neill, C., Bruins, W. S. C., Cosovic, M., Twickler, I., Verkleij, C. P. M., le Clerre, D., Themeli, M., Chion-Sotinel, I., Zweegman, S., Galetto, R., Mutis, T. & van de Donk, N. W. C. J., 25 Jul 2024, In: Journal for Immunotherapy of Cancer. 12, 7, e008769.Research output: Contribution to journal › Article › Academic › peer-review
-
Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing
Korst, C. L. B. M., Groen, K., Bosman, P. W. C., van der Valk, F., Verkleij, C. P. M., Kruyswijk, S., de Ruijter, M. E. M., Heijink, D. M., Kuipers, M. T., Zweegman, S. & van de Donk, N. W. C. J., 1 Jul 2024, In: HemaSphere. 8, 7, e132.Research output: Contribution to journal › Letter › Academic › peer-review
-
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS
de Jonge, A. V., Duetz, C., Bruins, W. S. C., Korst, C. L. B. M., Rentenaar, R., Cosovic, M., Eken, M., Twickler, I., Nijland, M., van der Poel, M. W. M., de Heer, K., Klerk, C. P. W., Strobbe, L., Oosterveld, M., Boersma, R., Koene, H. R., Roemer, M. G. M., van Werkhoven, E., Chamuleau, M. E. D. & Mutis, T., 12 Mar 2024, In: Blood. 8, 5, p. 1094-1104 11 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
